当前位置:产品中心>单抗/多抗

Anti-Human PD-L1&4-1BB/TNFRSF9/CD137&CD3&CD19 Multispecific Reference Antibody|抗人PD-L1、4-1BB/TNFRSF9/CD137、CD3和CD19多特异性参考抗体(靶标:人PD-L1/4-1BB/CD3/CD19)

货号:RB9T37015594
  • 价格:面议
  • 点击数:542
  

产品介绍

产品参数

形态Liquid
克隆性Monoclonal
抗体亚型(scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homo
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号P15391 & Q9NZQ7 & P07766 & Q07011
背景信息Emfizatamab is an anti-CD19/CD3E/TNFRSF9/PD-L1 monoclonal antibody.<br>
别名GNC038, GNC-038, GNC038, 2559704-23-1
备注For research use only. Not suitable for clinical or therapeutic use.